ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT APRIL 2026

Zinzino group revenue increased with a total of 21 %, compared with the previous year.

 

The revenue in April for Zinzino's sales markets increased by 22 % and amounted to SEK 300.8 (246.6) million. Faun Pharma's external sales decreased and amounted to SEK 4.6 (6.1) million. Overall, the Group increased revenues by 21 % to SEK 305.4 (252.7) million compared with the previous year.

Accumulated revenue for January - April 2026 increased by 26 % to SEK 1,227.5 (976.3) million.

Revenues were distributed as follows:

Regions, MSEK	26-Apr	25-Apr	Change	YTD 2026	YTD 2025	Change
The Nordics	24.6	23.4	5%	103.0	100.4	3%
Central Europe	88.8	64.7	37%	364.4	261.1	40%
East Europe	26.1	27.1	-4%	111.3	124.3	-10%
South & West Europe	49.9	43.9	14%	206.6	168.9	22%
The Baltics	9.5	8.5	12%	38.8	37.2	4%
North America	70.4	51.6	36%	262.8	161.8	62%
South America	4.0	0.7	471%	15.8	3.0	427%
Asia-Pacific	25.6	25.2	2%	92.7	91.0	2%
Africa	1.9	1.5	27%	8.3	6.5	28%
Zinzino	300.8	246.6	22%	1,203.7	954.2	26%
Faun Pharma	4.6	6.1	-25%	23.8	22.1	8%
Zinzino Group	305.4	252.7	21%	1,227.5	976.3	26%

 

Countries in regions:

-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden

-Central Europe: Austria, Germany, Switzerland

-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania

-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands

-The Baltics: Estonia, Latvia, Lithuania

-North America: Canada, USA, Mexico

-South America: Peru, Colombia

-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines, South Korea

-Africa: South Africa

 

For more information:

Dag Bergheim Pettersen CEO Zinzino [phone], [e-mail]

Fredrik Nielsen CFO Zinzino [phone], [e-mail]

 

Pictures for publication free of charge: [e-mail]

 

Certified Adviser: Tapper Partners AB

Zinzino is a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company's test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino's headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.

https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-april-2026,c4345098

https://mb.cision.com/Public/10976/4345098/ada3904202d4aa73.pdf

(c) 2026 Cision. All rights reserved., source Press Releases - English